An increased SET expression and decreased PP2A activity in follicle theca cells of Polycystic Ovary Syndrome (PCOS) patients have been cited to explain the hyperandrogenism in this disease [9,10]. This evidence concerns the gene SET and polycystic ovary syndrome.